ZA892275B - Combination therapy of il-2 and dtic for the treatment of melanoma - Google Patents

Combination therapy of il-2 and dtic for the treatment of melanoma

Info

Publication number
ZA892275B
ZA892275B ZA892275A ZA892275A ZA892275B ZA 892275 B ZA892275 B ZA 892275B ZA 892275 A ZA892275 A ZA 892275A ZA 892275 A ZA892275 A ZA 892275A ZA 892275 B ZA892275 B ZA 892275B
Authority
ZA
South Africa
Prior art keywords
dtic
melanoma
treatment
combination therapy
therapy
Prior art date
Application number
ZA892275A
Other languages
English (en)
Inventor
Carolyn M Paradise
M Paradise Carolyn
Edward C Bradley
C Bradley Edward
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Corp filed Critical Cetus Corp
Publication of ZA892275B publication Critical patent/ZA892275B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
ZA892275A 1988-03-28 1989-03-28 Combination therapy of il-2 and dtic for the treatment of melanoma ZA892275B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/174,000 US4999339A (en) 1988-03-28 1988-03-28 Combination therapy of IL-2 and DTIC for the treatment of melanoma

Publications (1)

Publication Number Publication Date
ZA892275B true ZA892275B (en) 1990-11-28

Family

ID=22634400

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA892275A ZA892275B (en) 1988-03-28 1989-03-28 Combination therapy of il-2 and dtic for the treatment of melanoma

Country Status (8)

Country Link
US (1) US4999339A (xx)
EP (1) EP0422010A1 (xx)
JP (1) JPH03503647A (xx)
KR (1) KR900700124A (xx)
AU (1) AU3427389A (xx)
IL (1) IL89750A0 (xx)
WO (1) WO1989009062A1 (xx)
ZA (1) ZA892275B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US5229109A (en) * 1992-04-14 1993-07-20 Board Of Regents, The University Of Texas System Low toxicity interleukin-2 analogues for use in immunotherapy
US20050100991A1 (en) * 2001-04-12 2005-05-12 Human Genome Sciences, Inc. Albumin fusion proteins
CA2405557C (en) 2000-04-12 2013-09-24 Human Genome Sciences, Inc. Albumin fusion proteins
CA2446739A1 (en) * 2001-05-25 2002-12-05 Human Genome Sciences, Inc. Chemokine beta-1 fusion proteins
AU2002364587A1 (en) * 2001-12-21 2003-07-30 Human Genome Sciences, Inc. Albumin fusion proteins
EP2261250B1 (en) * 2001-12-21 2015-07-01 Human Genome Sciences, Inc. GCSF-Albumin fusion proteins
EP1594530A4 (en) 2003-01-22 2006-10-11 Human Genome Sciences Inc HYBRID PROTEINS OF ALBUMIN
JP5650367B2 (ja) * 2004-02-27 2015-01-07 アンティセンス ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング 医薬組成物
US20080227762A1 (en) * 2004-03-02 2008-09-18 Wisconsin Alumni Research Foundation Lupeol anti-tumor agent and uses thereof
WO2013177187A2 (en) * 2012-05-22 2013-11-28 Massachusetts Institute Of Technology Synergistic tumor treatment with extended-pk il-2 and therapeutic agents
US9758786B2 (en) 2016-02-09 2017-09-12 Autotelic, Llc Compositions and methods for treating pancreatic cancer
WO2018215936A1 (en) 2017-05-24 2018-11-29 Novartis Ag Antibody-cytokine engrafted proteins and methods of use in the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518584A (en) * 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
AU7189087A (en) * 1986-04-24 1987-10-29 Cetus Corporation Combination therapy using interleukin-2 and glucocorticoid

Also Published As

Publication number Publication date
AU3427389A (en) 1989-10-16
KR900700124A (ko) 1990-08-11
WO1989009062A1 (en) 1989-10-05
EP0422010A1 (en) 1991-04-17
US4999339A (en) 1991-03-12
JPH03503647A (ja) 1991-08-15
IL89750A0 (en) 1989-09-28

Similar Documents

Publication Publication Date Title
ZA899058B (en) Treatment of obesity
GB2211709B (en) Multileaf collimator and related apparatus
GB2221390B (en) Niacin-containing composition and its therapeutic use
JPS6454092A (en) Solid scintillator and its treatment
GB8716133D0 (en) Treatment of materials
ZA892275B (en) Combination therapy of il-2 and dtic for the treatment of melanoma
PH24723A (en) Device and composition for treatment of the gums
GR890100571A (en) Disposition for the treatment of seeds
GB2214618B (en) Explosive devices and methods of use thereof
GB8310220D0 (en) Combination of support and pulley body
EP0185283A3 (en) Use of dihydropyridines for the treatment and prevention of arteriosclerosis
GB2220652B (en) Treatment of pastures
IE890938L (en) Synergistic use of il-2 and dtic for treating melanoma
GB8609317D0 (en) Treatment of keratinous materials
CS191088A1 (en) Device for treatment of cinder-oil and antuca surfaces
GB8827043D0 (en) Treatment of materials
GB8929197D0 (en) Sunbeds and suncanopies
GB2183157B (en) Treatment of cosmetic and like sticks
GR871342B (en) Belt and cushion for the treatment of slipped disk and lumbago
ZA893275B (en) Pharmaceutical composition for the treatment of migraine and the like
ZA897787B (en) Treatment of grain
ZA883119B (en) Substituted 5-pyrimidinecarboxamides and treatment of leukemia
GB8805885D0 (en) Treatment of onions
RU1833765C (en) Device for abrasive treatment of products
RU1833764C (en) Device for abrasive treatment of products